Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Chile raises COVID-19 spending, urges citizen caution with Delta variant circulating

Published 06/28/2021, 05:59 PM
Updated 06/28/2021, 06:01 PM
© Reuters. FILE PHOTO: A man waits outside a mobile vaccination centre to receive a dose of Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine in Santiago, Chile May 24, 2021. The sign reads ''I get vaccinated". REUTERS/Ivan Alvarado

By Aislinn Laing

SANTIAGO (Reuters) - Chile's President Sebastian Pinera on Monday announced a $2 billion boost to health spending to address the coronavirus pandemic, which continues to menace the country despite one of the world's fastest vaccination campaigns.

Pinera said the funds would be used to buy five million more vaccine doses, strengthen primary care facilities and testing, tracing and virus genome sequencing capability.

"The fight against COVID is not over and no one knows when it might be," said Pinera during a health briefing.

Alarm (NASDAQ:ALRM) is growing in Chile over the more contagious Delta variant of the coronavirus, which was confirmed in the country last week and has caused contagion spikes elsewhere.

Although it is experiencing a lull in cases after a fierce second wave, health chiefs have tightened health checks at borders and urged people to wear thicker masks.

Chile has vaccinated 82% of its 15 million target population with at least one dose and 70% are fully vaccinated against COVID-19. This week it is inoculating residents under age 18, as young as 12-years-old.

Pinera said the country will vaccinate children aged three to 11 as soon as regulatory approval is granted.

Studies suggest that two doses of the Pfizer/BioNTech or AstraZeneca (NASDAQ:AZN) vaccines - both being used in Chile - are broadly effective against Delta variant first identified in India and now rampaging around the globe.

Questions have been raised about whether Sinovac Biotech's CoronaVac primarily used in Chile can protect against the variant that has also been associated with more severe disease.

Last week, a researcher at China's Center for Disease Control said antibodies triggered by two Chinese COVID-19 vaccines he did not name were less effective against Delta than other variants, albeit still offering some protection.

Also last week, Italian Prime Minister Mario Draghi said China's COVID-19 vaccine "has shown itself to be inadequate," pointing to Chile's experience as proof.

Chile's Health Minister Enrique Paris said Draghi should correct himself, insisting the Sinovac shot was effective.

© Reuters. FILE PHOTO: A man waits outside a mobile vaccination centre to receive a dose of Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine in Santiago, Chile May 24, 2021. The sign reads ''I get vaccinated

"It really bothers me that a European authority should say the vaccine has not worked here without having any scientific information to back that up," Paris said.

Public health chief Paula Daza said it was "very likely" that Chile would issue a third dose to its citizens, potentially of a different vaccine from their previous shots, noting: "it might be a way of bolstering the effectiveness of vaccines."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.